(PharmaNewsWire.Com, January 26, 2017 ) BioPolymer GmbH & Co. KG (BioPolymer) is a medical equipment company that researches, develops, and produces hyaluronic acid-based products for orthopedics. The company offers products such as crespine gel and crespine gel plus. It caters its products to physicians, clinics and medical centers. BioPolymers products contain raw materials crosslinked in a way that makes the products stable in human body. The companys products offer optimized injection behavior that is reflected in the thixotropic properties of the hyaluronic acid. It has distributions in Africa, Asia, Australia, Europe, North America, and South America. BioPolymer is headquartered in Dummer, Germany. This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments The report analyzes all pipeline products in development for the company BioPolymer GmbH & Co. KG The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date. Reasons to Buy: Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio To formulate effective Research & Development strategies Develop market-entry and market expansion strategies Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
